READDI AViDD Center

READDI’s Antiviral Drug Discovery Center (AViDD Center) is a public-private partnership designed to identify and develop oral antivirals that can combat pandemic-level viruses. The COVID-19 pandemic and recent outbreaks like monkeypox and Sudan Ebolavirus have demonstrated the urgent need for effective antiviral therapies. To address this challenge, the READDI-AC platform brings together cutting-edge academic scientists and industry drug development expertise to develop broad spectrum antiviral drugs for four virus families of pandemic concern: coronaviruses, flaviviruses, filoviruses, and alphaviruses.

The READDI-AC site was designed as a sister site to READDI.org.

Both READDI-AC and READDI were designed while employed at Fassino/Design.

READDI’s sister site:

Back to Websites